Advanced search
Publication Cover
CRANIO®
The Journal of Craniomandibular & Sleep Practice
Volume 39, 2021 - Issue 1
Submit an article Journal homepage
146
Views
0
CrossRef citations to date
0
Altmetric
Guest Editorial

Current status of the application of botulinum toxin as a treatment option for trigeminal neuralgia

Valerie Chávez-Péreza Department of TMJ, Universitat Internacional de Catalunya, Barcelona, Spain
, DDS,
Natalia Felipe-Spadaa Department of TMJ, Universitat Internacional de Catalunya, Barcelona, Spain
, DDS, PhD,
Javier Roldán-Cuberob Department of Restorative Dentistry, Universitat Internacional de Catalunya, Barcelona, Spain
, DDS, MSc,
Patricia Freire-Nietoa Department of TMJ, Universitat Internacional de Catalunya, Barcelona, Spain
, DDS &
Jordi Tomàs-Aliberasc Department of TMJ, Universitat Internacional de Catalunya, Barcelona, Spain, [email protected]
, DDS, PhD
Pages 1-3 | Published online: 24 Dec 2020

References

  • Castillo-Álvarez F, Hernando de la Bárcena I, Marzo-Sola M. Toxina botulínica en la neuralgia del trigémino[Botulinum toxin in trigeminal neuralgia]. Medicina Clínica. 2017;148(1):28–32.
  • Kowacs P, Utiumi M, Nascimento F, et al. OnabotulinumtoxinA for trigeminal neuralgia: a review of the available data. Arquivos de Neuro- Psiquiatria. 2015;73(10):877–884. DOI:10.1590/0004-282X20150109
  • Guardiani E, Sadoughi B, Blitzer A, et al. A new treatment paradigm for trigeminal neuralgia using botulinum toxin type A. Laryngoscope. 2013;124(2):413–417.
  • Mittal S, Safarpour D, Jabbari B. Botulinum toxin treatment of neuropathic pain. Semin Neurol. 2016;36(1):073–083.
  • Rath G. Handbook of trigeminal neuralgia. Singapore, Singapore: Springer; 2019.
  • Burmeister J, Holle D, Bock E, et al. Botulinum neurotoxin type A in the treatment of classical trigeminal neuralgia (BoTN): study protocol for a randomized controlled trial. Trials. 2015;16:550.
  • Tepper S. Cranial neuralgias. Continuum: lifelong learning in neurology. Headache. 2018;24(4):1157–1178.
  • Morra M, Elgebaly A, Elmaraezy A, et al. Therapeutic efficacy and safety of botulinum toxin A therapy in trigeminal neuralgia: a systematic review and meta-analysis of randomized controlled trials. J Headache Pain. 2016;17(1):63. DOI:10.1186/s10194-016-0651-8.
  • Meng F, Peng K, Yang J, et al. Botulinum toxin-A for the treatment of neuralgia: a systematic review and meta-analysis. J Pain Res. 2018;11:2343–2351.
  • Park J, Park H. Botulinum toxin for the treatment of neuropathic pain. Toxins (Basel). 2017;9(9):260.
  • Crespi J, Bratbak D, Dodick D, et al. Pilot study of injection of OnabotulinumtoxinA toward the sphenopalatine ganglion for the treatment of classical trigeminal neuralgia. Headache. 2019;59(8):1229–1239. DOI:10.1111/head.13608.
  • Liu J, Xu Y, Zhang Q, et al. Efficacy and safety of botulinum toxin type A in treating patients of advanced age with idiopathic trigeminal neuralgia. Pain Res Manag. 2018;2018:1–5.
  • Lenaerts M, Green T. OnabotulinumtoxinA in migraine and other headaches: review and update. Curr Treat Options Neurol. 2019;21(4):21.
  • Fischoff D, Spivakovsky S. Botulinum toxin for facial neuralgia. Evid Based Dent. 2018;19(2):57–58.
  • Li S, Lian Y, Chen Y, et al. Therapeutic effect of botulinum toxin-A in 88 patients with trigeminal neuralgia with 14-month follow- up. J Headache Pain. 2014;15(1):43. DOI:10.1186/1129-2377-15-43.
  • Nathan N, Dieb W, Descroix V, et al. Topical review: potential use of botulinum toxin in the management of painful posttraumatic trigeminal neuropathy. J Oral Facial Pain Headache. 2017;31(1):7–18. DOI:10.11607/ofph.1753.
  • Shackleton T, Saravanen R, Black M, et al. The efficacy of botulinum toxin for the treatment of trigeminal and postherpetic neuralgia: a systematic review with meta-analyses. Br Dent J. 2016;221(8):475.
  • Wu C, Xie N, Liu H, et al. A new target for the treatment of trigeminal neuralgia with botulinum toxin type A. Neurol Sci. 2018;39(3):599–602. DOI:10.1007/s10072-017-3171-7.
  • Xia J, He C, Zhang H, et al. Botulinum toxin A in the treatment of trigeminal neuralgia. Int J Neurosci. 2016;126(4):348–353. DOI:10.3109/00207454.2015.1019624.
  • Yang K, Kim M, Ju J, et al. Antinociceptive effects of botulinum toxin type A on trigeminal neuropathic pain. J Dent Res. 2016;95(10):1183–1190. DOI:10.1177/0022034516659278.
  • Zhang H, Lian Y, Xie N, et al. Single-dose botulinum toxin type A compared with repeated-dose for treatment of trigeminal neuralgia: a pilot study. J Headache Pain. 2017;18(1):81.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.